The cholinergic system in aging and neuronal degeneration.
By R. Schliebs, T. Arendt. Behavioural Brain Research, 2011
1,028 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Pharmacology, Physiology
View Paper: https://www.semanticscholar.org/paper/23e17c80fa7dbc11133eddad8405dd7cec1b1319
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
In Physiology
Citations in the corpus
- Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease (2017, neutral): “pocampus is well-documented in AD [168].”
- The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. (2018, background): “It is well accepted that the interactions of NGF with the forebrain cholinergic system is of significance in Alzheimer’s disease (Mufson et al., 2008; Schliebs and Arendt, 2011; Cattaneo and Calissano, 2012; Triaca and Calissano, 2016; Turnbull et al., 2018).”
- Therapeutic effects of non-invasive brain stimulation with direct currents (tDCS) in neuropsychiatric diseases (2014, neutral): “, 2002) caused by cholinergic, GABA-ergic, and glutamatergic dysfunction (Iwakiri et al., 2005; Parameshwaran et al., 2008; Schliebs and Arendt, 2011; Yamin, 2009), amongst others, leading to impaired plasticity, and oscillatory activity, and thus causing cognitive deficits.”